FMS News and Press, Fresenius Medical Care AG From 10/18/23

2023-10-18 08:15:00 ET Summary The S&P 500 and Dow Jones Industrial Average saw sharp losses for the month and the quarter. Interest rates were kept steady in a range of 5.25% to 5.5%, and it is uncertain if 2023 will see yet another hike. Net investments of around $1,500 ...

Capital Square Delivers 149.59% Total Return* to Investors in Medical Building DST PR Newswire WINCHESTER, Va. , Oct. 18, 2023 /PRNewswire/ -- Capital Square , one of the nation's leading sponsors of tax-advantaged real estate investments and an active develo...

2023-10-14 11:05:00 ET Summary We are value investors. In constructing portfolios for our clients, we seek out companies that we believe are trading in the market at significant discounts to their underlying value. These businesses must offer significant profit potential and be run by...

2023-10-13 08:00:00 ET Summary Investors are pulling out of the stock market and into lower-yielding investments like T-bills, causing stock prices to drop. REITs, such as Agree Realty and Realty Income, have seen their prices decline, presenting an opportunity for investors. ...

2023-10-12 15:39:22 ET More on Fresenius Medical Care Fresenius Medical Care: Don't Let The Ozempic Kidney Failure Scare You Off Fresenius Medical Care AG & Co. KGaA (FMS) Q2 2023 Earnings Call Transcript Fresenius Medical Care: Heads Don't Roll - They Run ...

2023-10-12 13:29:16 ET Summary Fresenius Medical Care (FMS) and Fresenius (FRE) stocks have experienced a decline due to the Novo Nordisk drug Ozempic ending a kidney failure study early. FMS remains a good player in the dialysis field and is not fundamentally impacted by the Ozem...

2023-10-12 13:24:12 ET More on Baxter, DaVita, etc. Should You Buy Baxter Or DaVita After The Fallout From The Ozempic Trial? Outset Medical Faces Regulatory Delays Amid Heavy Cash Burn (Rating Downgrade) DaVita: Continued Economic Hurdles, Market Expectations May Be...

2023-10-11 14:51:11 ET More on DaVita DaVita: Continued Economic Hurdles, Market Expectations May Be Correct DaVita stock sell-off over Ozempic study 'big overreaction,' says UBS DaVita: Breakout Not Supported Without Leverage Effects, Reiterate Hold ...

2023-10-11 12:51:59 ET Shares of several major dialysis stocks plunged on Wednesday after Novo Nordisk (NYSE: NVO) indicated one of its diabetes treatments could also be used to treat chronic kidney disease. Dialysis products and services providers were broadly negative in early...

2023-10-11 12:18:08 ET Shares of Fresenius Medical Care (NYSE: FMS) were down more than 18% as of noon ET on Wednesday. The healthcare company's shares are up a little more than 5% so far this year. The drop came because a competitor's drug fared well in preventing kidney diseas...